Asunto(s)
Amenaza de Aborto/diagnóstico , Progesterona/sangre , Amenaza de Aborto/sangre , Femenino , Humanos , Embarazo , Pronóstico , RadioinmunoensayoRESUMEN
The case-series of the Institute of Obstetrics and Gynaecology were examined to evaluate the suitability of urinary estriol, total plasma estriol, unconjugated plasma estriol, unconjugated plasma estetrol, plasma placental lactogen, plasma S.P.-1 glycoprotein, plasma alphafetoprotein and biparietal diameter in correctly forecasting the perinatal risk, when performed after the 25th week of pregnancy. In high-risk pregnancies, according to our results, S.P.-1 glycoprotein and urinary estriol are the most sensitive tests, while S.P.-1 glycoprotein, placental lactogen and biparietal diameter are found to have the highest predictive value. The repetition of the considered tests increases their sensitivity, but not their predictive value. In pregnancy mass screening the most suitable tests, on the basis of the "relative risk" are S.P.-1 glycoprotein (or even placental lactogen), estriol and biparietal diameter. For the last one a single measurement seems to be enough during the third trimester.
Asunto(s)
Pruebas de Función Placentaria , Tercer Trimestre del Embarazo , Estetrol/sangre , Estriol/sangre , Estriol/orina , Femenino , Glicoproteínas/sangre , Humanos , Lactógeno Placentario/sangre , Embarazo , Riesgo , alfa-Fetoproteínas/metabolismoRESUMEN
The administration of betamethasone to the mother in order to accelerate maturation of foetal lungs induces significant modifications in the foeto-placental hormonal secretion. Both the total estriol and unconjugated estriol present a sharp fall in the days immediately following the administration and a rise 10-12 days later, depending on a rebound effect. The HPL levels do not variate except for a progressive and constant rising due probably to better cardiocirculatory maternal condition with, consequently, a higher utero-placental blood-flow. All these phenomena increase when the administration of betamethasone to the mother is repeated more then once. The AA. believe that the sharp fall of the estriol doesn't represent a danger for the foetus being only an effect of maternal and fetal adrenal depression. Consequently the AA. suggest to drive the management during and after the administration of betamethasone to the mother on the basis of other foeto-placental functional tests, as cardiotocography. The results were analysed.
Asunto(s)
Betametasona/uso terapéutico , Estriol/sangre , Monitoreo Fetal , Lactógeno Placentario/sangre , Síndrome de Dificultad Respiratoria del Recién Nacido/prevención & control , Femenino , Humanos , Recién Nacido , Embarazo , Síndrome de Dificultad Respiratoria del Recién Nacido/sangreRESUMEN
A case of a woman affected by a nephrotic postnephritic syndrome and treated during pregnancy with cortisone and prednisolone, is reported. The patient delivered at the 40th week of gestation a neonate with no malformations or clinical signs of adrenal deficiency. No interference between corticosteroid therapy and estrogen metabolism was noticed, and the intrauterine fetal growth, evaluated measuring the biparietal diameter, appeared normal.